Scout | Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)

This grant opportunity aims to support research focused on tackling HIV infection in individuals with substance use disorders (SUD). It seeks proposals for projects that will: (1) Identify targets and pathways to suppress HIV transcription in HIV reservoirs, such as the central nervous system, in people with SUD. (2) Apply new drug discovery methods to find compounds that could help suppress H…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: December 20, 2023

Open for Submission: December 20, 2023

Submission Deadline: August 13, 2024

Application Window Closes: August 13, 2024

Keywords

HIV

Substance Use Disorders

Chemical Probes

Small Molecule Drug Discovery

HIV Transcription

Neuropathological Complications

Viral Latency

CNS

Pharmacological Probes

HIV-SUD Comorbidity

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers